IMNM Stock Forecast 2024: Immunome Inc Remains Weak With A Upside Of 26.59%
In the last trading session, 1.88 million shares of the Immunome Inc (NASDAQ:IMNM) were traded, and its beta was 1.79. Most recently the company’s share
In the last trading session, 1.88 million shares of the Immunome Inc (NASDAQ:IMNM) were traded, and its beta was 1.79. Most recently the company’s share
Immunome Inc (NASDAQ:IMNM)’s traded shares stood at 3.17 million during the last session, with the company’s beta value hitting 1.78. At the close of trading,
In last trading session, Immunome Inc (NASDAQ:IMNM) saw 0.55 million shares changing hands with its beta currently measuring 1.81. Company’s recent per share price level
During the last session, Immunome Inc (NASDAQ:IMNM)’s traded shares were 0.63 million, with the beta value of the company hitting 1.82. At the end of
During the last session, Immunome Inc (NASDAQ:IMNM)’s traded shares were 0.72 million, with the beta value of the company hitting 1.79. At the end of
Immunome Inc (NASDAQ:IMNM)’s traded shares stood at 0.54 million during the last session, with the company’s beta value hitting 1.79. At the close of trading,
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.